Access to HealthEnvironmental SustainabilityEmployeesEthics Transparency

Our Giving


Our Giving

It’s not enough to discover and develop new medicines and vaccines. We also need to help get them to the people who need them.

One important way to achieve that goal is through donations of medicines and vaccines that address specific health needs, whether in communities with a fundamental lack of access to health care and services or in acute or protracted humanitarian crises.

Our product donation programs and initiatives include:

  • The MECTIZAN® Donation Program—one of the most significant initiatives undertaken by our company to help improve access to medicines in developing countries. Established more than 25 years ago, the MECTIZAN Donation Program is the longest-running disease-specific drug donation program and public-private partnership of its kind, and is widely regarded as one of the most successful public-private health collaborations in the world.
  • Our Medical Outreach Program—the primary mechanism through which we donate our pharmaceuticals and vaccines for humanitarian assistance in the developing world and in support of disaster relief and emergency response worldwide
  • U.S. Patient Assistance Programs—We provide our company’s medicines and adult vaccines free of charge to people who do not have prescription drug or health insurance coverage and who, without our assistance, could not otherwise afford them


Product Donations
MECTIZAN® (ivermectin)20112012201320142015
Direct investment in the MECTIZAN Donation Program (in millions)$5.5$5.5$5.5$5.5$5.8
Total treatments approved (in millions)1233.5229.0295.0257.0176.0
Treatments approved for river blindness104851283955
Treatments approved for lymphatic filariasis (LF)9310912714794
Treatments approved for joint river blindness and LF programs36.535407127
Market value of MECTIZAN donations (in millions)$747$906$1,092$861$1,083
Medical Outreach Program (MMOP)
Value of donations of medicines, vaccines and consumer care products (in millions)2,3,4$89.8$86.3$69.4$110.2$31.1
Disaster relief contributions (product) (in millions)2$10.40$0.78$2.40$8.50$4.7
U.S. Patient Assistance Programs
30-day prescriptions filled (millions)
Total value of our company's medicines dispensed (in millions)5$301.2$559.0$566.4$432.9$566.6
1 Additional detail from previous reports to provide more detailed breakdown of donation by disease
2 We set the value of our product donations based on the U.S. wholesale acquisition cost.
3 Figure includes the value of product donations through the MMOP program only. Product donations to ACHAP are included in the ACHAP section.
4 The 2014 figure does not include donations of our company's consumer care items. All our consumer care donations made in 2014 are captured in the subsidiary and divisional figure ($2.8M in 2014). Effective October 1, 2014, Bayer AG purchased our company's consumer Care business.
5 Totals are based on the U.S. wholesale acquisition cost (WAC) and cover all programs.